Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
BMC Biotechnology|March 26, 2011
Rapid obtention of stable, bioluminescent tumor cell lines using a tCD2-luciferase chimeric constructAnne-Sophie Jimenez, Mélanie Gressette, Clément Barjon, et al.
Cancer Research|March 26, 2002
Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumorsWen-hai Feng, Bruce Israel, Nancy Raab-Traub, et al.
Expert Opinion on Therapeutic Targets|April 7, 2020
Emerging therapeutic targets for nasopharyngeal carcinoma: opportunities and challengesValentin Baloche, François-Régis Ferrand, Anna Makowska, et al.
Translational Oncology|July 12, 2019
Interferon β and Anti-PD-1/PD-L1 Checkpoint Blockade Cooperate in NK Cell-Mediated Killing of Nasopharyngeal Carcinoma CellsAnna Makowska, Till Braunschweig, Bernd Denecke, et al.
International Journal of Molecular Sciences|October 28, 2023
Necrotic Cells from Head and Neck Carcinomas Release Biomolecules That Are Activating Toll-like Receptor 3Tea Vasiljevic, Marko Tarle, Koraljka Hat, et al.
Cancer Immunology, Immunotherapy : CII|July 18, 2019
Interferon beta increases NK cell cytotoxicity against tumor cells in patients with nasopharyngeal carcinoma via tumor necrosis factor apoptosis-inducing ligandAnna Makowska, Sabrina Franzen, Till Braunschweig, et al.
Cancer Detection and Prevention|August 2, 2003
Similar BCL-X but different BCL-2 levels in the two age groups of north African nasopharyngeal carcinomasAbdelmajid Khabir, Abdelmoneem Ghorbel, Jamel Daoud, et al.
Cells|September 28, 2021
Radiotherapy Combined with PD-1 Inhibition Increases NK Cell Cytotoxicity towards Nasopharyngeal Carcinoma CellsAnna Makowska, Nora Lelabi, Christina Nothbaum, et al.
Pageof 9